Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis.
Andonopoulos
A P
AP
Department of Medicine, Division of Rheumatology, University of Patras School of Medicine, Patras, Greece. andandon@med.upatras.gr
Meimaris
N
N
Daoussis
D
D
Bounas
A
A
Giannopoulos
G
G
D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D013997:Time Factors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab